mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.34 |
0.2 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |